Job description
Job Description
General Summary:
This position will work closely with the country commercial and market access teams as well as cross-functional Heme teams The incumbent is also expected to work with the Global Pricing and Market Access and Global and INTL HEOR teams. This position provides insights into global pricing market access strategies and works cross-functionally to shape the environment for access to ensure reimbursement approval for exa-cel.
Key Duties and Responsibilities:
One point of contact in International Pricing and Market Access for Heme.
- As a core member of the International cross functional Heme team, ensures that the pricing and access perspective is adequately represented in all strategic discussions; influences without authority to ensure that appropriate due diligence (scenario planning, analysis, recommendation) takes place in instances where the market access / payer perspective may differ from that of other functions.
- Maintains a good grasp of up to date payer insights for the cell & gene therapeutic area for Tier 1 and Tier 2 and countries to inform Global strategy.
- Informs Global Pricing and Market Access strategy, acting as one of the point of contact in the International region for Heme, providing input into: evidence generation plan (especially RWE projects), support for countries during upcoming line extensions for pricing, access potential and payer value story, regulatory and label considerations.
- Supports countries in scope to ensure that they each brand have appropriate Market Access plans in place to execute global strategy, in the context of the local payer environment. Ahead of each negotiation, ensures that each country has a negotiation flow in place, with clear value arguments, starting and last-offer prices.
Knowledge and Skills:
Significant experience in the pharmaceutical industry including prior market access roles, or in the market access space (e.g., consulting, payer experience)
- Solid analytical and quantitative skills demonstrated by deliverables in recent position.
- Demonstrated ability to successfully lead cross-functional teams, influencing without direct authority, with the interpersonal skills to foster collaboration and succeed in a highly matrixed environment.
Education and Experience:
- Bachelor's degree in relevant field
- Relevant experience in a similar role or the equivalent combination of education and experience
#LI-KJ1
#LI-Hybrid
Company Information
Vertex is a global biotechnology company that invests in scientific innovation.
Vertex is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, sex, gender identity or expression, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, sexual orientation, marital status, or any characteristic protected under applicable law. Vertex is an E-Verify Employer in the United States. Vertex will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Please note that Vertex requires COVID-19 vaccination for all employees working in the U.S. as a condition of employment at Vertex, subject to medical, religious or other accommodations or exemptions required by law. We believe this requirement is vital to keeping everyone at Vertex and in our communities safe. This requirement applies to both existing and new employees who may at any time work on-site at a Vertex facility or visit another location on behalf of Vertex (e.g., conferences, customer visits, etc.), including all remote employees. Any applicant requiring an accommodation in connection with the hiring process and/or to perform the essential functions of the position for which the applicant has applied should make a request to the recruiter or hiring manager, or contact Talent Acquisition at [email protected].
Vertex Pharmaceuticals
www.vrtx.com
Boston, United States
Reshma Kewalramani
$5 to $10 billion (USD)
1001 to 5000 Employees
Company - Public
Biotech & Pharmaceuticals
1989